Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | HMGCR | P04035 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10886003 | 1.00 | TSHR (0.68) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL28214293 | 1.00 | TSHR (0.68) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL8413428 | 1.00 | TSHR (0.68) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL8412547 | 1.00 | TSHR (0.68) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL8413427 | 1.00 | TSHR (0.68) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL27216011 | 0.95 | TSHR (0.60) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL8410683 | 0.95 | TSHR (0.60) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL3317342 | 0.95 | TSHR (0.60) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL28329337 | 0.95 | TSHR (0.60) | TSHRALDH1A1PTPN7TDP1HMGCR | |
| SCHEMBL11870055 | 0.93 | TSHR (0.59) | TSHRALDH1A1PTPN7TDP1HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3556464-B1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | SHINETSU CHEMICAL CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-3556464-B1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | SHINETSU CHEMICAL CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-110386863-B | Method for producing reduced halide having reduced carbon-carbon unsaturated bond | 信越化学工业株式会社 | 2023-02-28 | — | — | CN | disclosed |
| US-10676417-B2 | Method for producing reduced halide compound having undergone reduction of carbon-carbon unsaturated bond | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-06-09 | — | — | US | disclosed |
| US-10676417-B2 | Method for producing reduced halide compound having undergone reduction of carbon-carbon unsaturated bond | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-06-09 | — | — | US | disclosed |
| US-20190322607-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| US-20190322607-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| EP-3556464-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-10-23 | — | — | EP | disclosed |
| EP-3556464-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322607-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | CBR1, CBR3, DECR1 | TSHR 2420/4885ALDH1A1 907/4885PTPN7 4579/4885 |
| US-10676417-B2 | Method for producing reduced halide compound having undergone reduction of carbon-carbon unsaturated bond | CBR1, CBR3, DECR1 | TSHR 2420/4885ALDH1A1 907/4885PTPN7 4579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.